Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating both early and late onset alopecia areata.

Improved CRBN ligands make protein degraders more effective and drug-like.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Most patients experienced significant but reversible hair loss during treatment.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Valproic acid is effective for various seizures, but may cause temporary side effects like drowsiness and stomach issues.

Porocarcinoma generally has low rates of recurrence, spread to lymph nodes, and death.

Gefitinib therapy can cause unusual hair growth on the nose.

Tangent screens help detect visual field defects from vigabatrin.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

EE/CMA is more effective than EE/LNG in reducing acne.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

TEDAR is crucial for skin cell differentiation and barrier formation.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Clascoterone cream was approved in the USA for treating acne in people aged 12 and older.

A lotion with tretinoin, minoxidil, and betamethasone valerate helped treat a woman's skin infection.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.